LifeMD, Inc. (NASDAQ:LFMDP) Short Interest Up 100.0% in March

LifeMD, Inc. (NASDAQ:LFMDP) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 400 shares, a growth of 100.0% from the February 28th total of 200 shares. Based on an average trading volume of 2,700 shares, the short-interest ratio is currently 0.1 days.

LifeMD Stock Performance

Shares of LFMDP traded up $0.14 during midday trading on Friday, hitting $24.89. 1,538 shares of the stock traded hands, compared to its average volume of 2,747. The business’s 50 day moving average price is $22.86 and its two-hundred day moving average price is $22.56. LifeMD has a 1-year low of $20.25 and a 1-year high of $27.44.

LifeMD Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Friday, April 4th will be paid a dividend of $0.5547 per share. This represents a $2.22 dividend on an annualized basis and a yield of 8.91%. The ex-dividend date of this dividend is Friday, April 4th.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.